Post-Release Substance Abuse Outcomes Among HIV-Infected Jail Detainees: Results from a Multisite Study.

Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, 135 College St., Suite 323, New Haven, CT, 06510-2283, USA, .
AIDS and Behavior (Impact Factor: 3.49). 11/2012; 17(S2). DOI: 10.1007/s10461-012-0362-3
Source: PubMed

ABSTRACT HIV-infected individuals with substance use disorders have a high prevalence of medical and psychiatric morbidities that complicate treatment. Incarceration further disrupts healthcare access and utilization. Without appropriate diagnosis and treatment, drug relapse upon release exceeds 85 %, which contributes to poor health outcomes. A prospective cohort of 1,032 HIV-infected jail detainees were surveyed in a ten-site demonstration project during incarceration and six-months post-release, in order to examine the effect of predisposing factors, enabling resources and need factors on their subsequent drug use. Homelessness, pre-incarceration cocaine and opioid use, and high drug and alcohol severity were significantly associated with cocaine and opioid relapse. Substance abuse treatment, though poorly defined, did not influence post-release cocaine and opioid use. An approach that integrates multiple services, simultaneously using evidence-based substance abuse, psychiatric care, and social services is needed to improve healthcare outcomes for HIV-infected persons transitioning from jails to the community.

Download full-text


Available from: Frederick Altice, Jan 09, 2014
1 Follower
  • Source
    • "Additionally, in the presence of active substance use, inadequate diagnosis and treatment of PDs in community settings unwittingly contribute to the overburdened CJS (Draine et al. 2002), which struggles with insufficient resources, yet these structured settings makes them suitable for standardized screening and treatment algorithms (Finkelstein et al. 2005; Maruschak and Beavers 2009; Kamath et al. 2013). Consequences of undiagnosed and under-treated PDs among PLWHA can result in poor treatment outcomes for those transitioning to the community where the highly structured prison setting is discontinued, resulting in poor access and adherence to combination antiretroviral therapy (cART) (Springer et al. 2012; Meyer et al. 2011), suboptimal viral suppression (Uldall et al. 2004; Springer et al. 2004; Meyer et al. 2011; Meyer et al. 2014) and increased HIV risk-taking behaviors (Goforth and Fernandez 2011; Buckingham et al. 2013), repeated incarcerations (Baillargeon et al. 2009; Baillargeon et al. 2010a; Baillargeon et al. 2010b), relapse to drug and alcohol use (Krishnan et al. 2013), decreased retention in HIV care (Althoff et al. 2013), a high frequency of emergency department visits (Meyer et al. 2012, 2013), and a higher risk of death (DeLorenze et al. 2010). Thus, correctly identifying and treating PDs among HIV-infected prisoners prior to release is crucial for effective transitional care of PLWHA who re-enter the community (Springer et al. 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The criminal justice system (CJS), specifically prisons and jails, is ideally suited for uniform screening of psychiatric (PD) and substance use disorders (SUDs) among people living with HIV/AIDS (PLWHA), who are concentrated in these settings. By accurately diagnosing PDs and SUDs in these controlled settings, treatment can be initiated and contribute to improved continuity of care upon release. In the context of PLWHA, it may also improve combination antiretroviral treatment (cART) adherence, and reduce HIV transmission risk behaviors. A retrospective data analysis was conducted by creating a cohort of PLWHA transitioning to the community from prison or jail enrolled who were enrolled in a controlled trial of directly administered antiretroviral (DAART). Participants were systematically assessed for PDs and SUDs using the Mini International Neuropsychiatric Interview (MINI), a standardized psychiatric assessment tool, and compared to diagnoses documented within the correctional medical record. Findings confirm a high prevalence of Axis I PDs (47.4%) and SUDs (67.1%) in PLWHA even after prolonged abstinence from alcohol and drugs. Although prevalence of PDs and SUDs were high in the medical record, there was fair to poor agreement among PDs using the MINI, making evident the potential benefit of more objective and concurrent PD assessments to guide treatment. Additional PD diagnoses may be detected in PLWHA in CJS using supplementary and objective screening tools. By identifying and treating PDs and SUDs in the CJS, care may be improved and may ultimately contribute to healthier outcomes after community release if patients are effectively transitioned.
    10/2014; 2(11). DOI:10.1186/s40352-014-0011-1
  • Source
    • "b For categorical variables, chi-squared was used. An independent samples t-test was used for continuous level variables (Draine et al., 2011; Chen et al., 2011; Chitsaz et al., 2013; Krishnan et al., 2012). Women in this sample were significantly more likely than men to report being homo/bisexual (30.4 vs 5.1 percent) or having diagnosed bipolar disorder (26.1 vs 6.8 percent) but were similar to men in terms of all other demographic, HIV health outcomes, mental disorders, and substance use indicators (data not shown). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Little is known about the association of intimate partner violence (IPV) with specific HIV treatment outcomes, especially among criminal justice (CJ) populations who are disproportionately affected by IPV, HIV, mental and substance use disorders (SUDs) and are at high risk of poor post-release continuity of care. Mixed methods were used to describe the prevalence, severity, and correlates of lifetime IPV exposure among HIV-infected jail detainees enrolled in a novel jail-release demonstration project in Connecticut. Additionally, the effect of IPV on HIV treatment outcomes and longitudinal healthcare utilization was examined. Structured baseline surveys defined 49% of 84 participants as having significant IPV-exposure, which was associated with female gender, longer duration since HIV diagnosis, suicidal ideation, having higher alcohol use severity, having experienced other forms of childhood and adulthood abuse, and homo/bisexual orientation. IPV was not directly correlated with HIV healthcare utilization or treatment outcomes. In-depth qualitative interviews with 20 surveyed participants, however, confirmed that IPV was associated with disengagement from HIV care especially in the context of overlapping vulnerabilities, including transitioning from CJ to community settings, having untreated mental disorders, and actively using drugs or alcohol at the time of incarceration. Post-release interventions for HIV-infected CJ populations should minimally integrate HIV secondary prevention with violence reduction and treatment for SUDs.
    International Journal of Prisoner Health 09/2013; 9(3):124-141. DOI:10.1108/IJPH-03-2013-0011
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background HIV-infected prisoners have a high prevalence of alcohol use disorders and commonly relapse to alcohol soon after release to the community which is linked to high morbidity, poor antiretroviral therapy (ART) adherence and increased sexual risk-taking behaviors. Extended-release naltrexone (XR-NTX) effectively reduces relapse to alcohol in alcohol dependent persons, yet it remains unexamined among criminal justice system (CJS) populations transitioning to the community. Methods A randomized double-blind, placebo-controlled trial of XR-NTX to improve HIV treatment outcomes via reducing relapse to alcohol use after prison release for HIV-infected hazardous drinking and alcohol dependent prisoners is discussed. Results Acceptability of study participation is high with 86% of those referred who met eligibility criteria and 85% of those who were able to receive injections prior to release accepted injections, yet important implementation issues are identified and addressed during the study and are discussed in this paper. Conclusion Medication-assisted therapies for prevention of relapse to alcohol use for CJS populations transitioning to the community, especially for HIV-infected patients, are urgently needed in order to reduce alcohol relapse after release and improve HIV treatment outcomes and contribute to improved individual and public health.
    Contemporary clinical trials 01/2013; 37(2). DOI:10.1016/j.cct.2013.12.006 · 1.99 Impact Factor
Show more